Literature DB >> 23139101

Th2 responses in schistosomiasis.

Keke Fairfax1, Marcia Nascimento, Stanley Ching-Cheng Huang, Bart Everts, Edward J Pearce.   

Abstract

Schistosomiasis is caused by infection with parasitic flatworms of the genus Schistosoma. It is characterized by the development of strong CD4(+) T cell and B cell responses that, during primary infection, fail to eliminate the parasites, but in collaboration with cells of the innate immune system allow survival in the face of ongoing tissue damage caused by the lodging of parasite eggs in the liver and the passage of eggs across the intestinal epithelium. Mounting a tightly controlled Th2 response is key to this outcome, and while this type of response is a risk factor for the development of fibrosis, it also underpins the development of resistance to further infection; as such, understanding how Th2 responses are induced and regulated in schistosomiasis remains a critical area of research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139101     DOI: 10.1007/s00281-012-0354-4

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  106 in total

1.  IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni.

Authors:  S C Bosshardt; G L Freeman; W E Secor; D G Colley
Journal:  Parasite Immunol       Date:  1997-08       Impact factor: 2.280

2.  Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.

Authors:  P G Fallon; E J Richardson; G J McKenzie; A N McKenzie
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

3.  Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model.

Authors:  Sylvie Amu; Sean P Saunders; Mitchell Kronenberg; Niamh E Mangan; Ann Atzberger; Padraic G Fallon
Journal:  J Allergy Clin Immunol       Date:  2010-03-20       Impact factor: 10.793

4.  Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection.

Authors:  Shona Wilson; Frances M Jones; Joseph K Mwatha; Gachuhi Kimani; Mark Booth; H Curtis Kariuki; Birgitte J Vennervald; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

5.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

6.  Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin.

Authors:  Thirumalai R Ramalingam; John T Pesce; Margaret M Mentink-Kane; Satish Madala; Allen W Cheever; Michael R Comeau; Steven F Ziegler; Thomas A Wynn
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

Review 7.  Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria.

Authors:  Shona Wilson; Birgitte J Vennervald; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2011-08-30

8.  Proteomic identification of IPSE/alpha-1 as a major hepatotoxin secreted by Schistosoma mansoni eggs.

Authors:  Maha-Hamadien Abdulla; Kee-Chong Lim; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2011-10-25

9.  MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity.

Authors:  Jacqueline G Perrigoue; Steven A Saenz; Mark C Siracusa; Eric J Allenspach; Betsy C Taylor; Paul R Giacomin; Meera G Nair; Yurong Du; Colby Zaph; Nico van Rooijen; Michael R Comeau; Edward J Pearce; Terri M Laufer; David Artis
Journal:  Nat Immunol       Date:  2009-05-24       Impact factor: 25.606

10.  Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.

Authors:  John T Pesce; Thirumalai R Ramalingam; Margaret M Mentink-Kane; Mark S Wilson; Karim C El Kasmi; Amber M Smith; Robert W Thompson; Allen W Cheever; Peter J Murray; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more
  56 in total

1.  Specific humoral response of hosts with variable schistosomiasis susceptibility.

Authors:  Patrick Driguez; Hamish E G McWilliam; Soraya Gaze; David Piedrafita; Mark S Pearson; Rie Nakajima; Mary Duke; Angela Trieu; Denise L Doolan; Fernanda C Cardoso; Algis Jasinskas; Geoffrey N Gobert; Philip L Felgner; Alex Loukas; Els Meeusen; Donald P McManus
Journal:  Immunol Cell Biol       Date:  2015-06-05       Impact factor: 5.126

Review 2.  The effects of helminth infections against type 2 diabetes.

Authors:  Yan-Ru Gao; Rong-Hui Zhang; Ru Li; Chun-Lian Tang; Qun Pan; Peng Pen
Journal:  Parasitol Res       Date:  2021-05-18       Impact factor: 2.289

3.  The role of ST2 and ST2 genetic variants in schistosomiasis.

Authors:  Xin Long; Michelle Daya; Jianping Zhao; Nicholas Rafaels; Huifang Liang; Joseph Potee; Monica Campbell; Bixiang Zhang; Maria Ilma Araujo; Ricardo R Oliveira; Rasika A Mathias; Li Gao; Ingo Ruczinski; Steve N Georas; Donata Vercelli; Terri H Beaty; Kathleen C Barnes; Xiaoping Chen; Qian Chen
Journal:  J Allergy Clin Immunol       Date:  2017-02-09       Impact factor: 10.793

Review 4.  NLR proteins and parasitic disease.

Authors:  Gwendolyn M Clay; Fayyaz S Sutterwala; Mary E Wilson
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Schistosomal extracellular vesicle-enclosed miRNAs modulate host T helper cell differentiation.

Authors:  Tal Meningher; Yiftah Barsheshet; Yifat Ofir-Birin; Daniel Gold; Boris Brant; Elya Dekel; Yechezkel Sidi; Eli Schwartz; Neta Regev-Rudzki; Orly Avni; Dror Avni
Journal:  EMBO Rep       Date:  2019-12-11       Impact factor: 8.807

6.  Interleukin-33 promotes Th2 immune responses in infected mice with Schistosoma japonicum.

Authors:  Yihan Yu; Weiwen Deng; Jiahui Lei
Journal:  Parasitol Res       Date:  2015-05-06       Impact factor: 2.289

7.  Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

Review 8.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

9.  Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ.

Authors:  Thirumalai R Ramalingam; Richard L Gieseck; Thomas H Acciani; Kevin M Hart; Allen W Cheever; Margaret M Mentink-Kane; Kevin M Vannella; Thomas A Wynn
Journal:  J Pathol       Date:  2016-06-10       Impact factor: 7.996

10.  Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.

Authors:  Sylvie M Mimche; Beatrice A Nyagode; Matthew D Merrell; Choon-Myung Lee; Nina S Prasanphanich; Richard D Cummings; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-10-25       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.